跳至主要内容
临床试验/NCT03293927
NCT03293927撤回2 期

Investigating Polypharmacy-related Adverse Events in Critically Ill Children

Duke University1 个研究点 分布在 1 个国家开始时间: 2018年4月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Change in delirium scores as measured by CAPD score

研究概览

简要总结

The purpose of this study is to learn how 2 medications (fentanyl and dexmedetomidine) affect how sick children think and interact with their environments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
2 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Ages 2-<18 at the time of enrollment
  • Admitted to the Duke PICU or PCICU
  • Planned or anticipated mechanically ventilation for ≥2 days
  • Require sedation to maintain mechanical ventilation
  • No contraindication to receipt of fentanyl or dexmedetomidine per clinician judgment
  • Availability and willingness of the parent/legal guardian to provide written informed consent

排除标准

  • Any concomitant condition, which in the opinion of the investigator would preclude a subject's participation in the study.
  • Previous participation in this study
  • Planned receipt of sedatives other than fentanyl or dexmedetomidine
  • Participants with any of the following diagnoses: traumatic brain injury, intracranial hemorrhage, baseline neurodevelopmental delay, status epilepticus, or requiring inotropic support for hemodynamic stability.
  • Renal failure requiring renal replacement therapy
  • Hepatic failure
  • Support with extracorporeal membrane oxygenation

研究组 & 干预措施

Fentanyl + Dexmedetomidine

Experimental

干预措施: Fentanyl (Drug)

Fentanyl + Dexmedetomidine

Experimental

干预措施: Dexmedetomidine (Drug)

Dexmedetomidine + Fentanyl

Experimental

干预措施: Fentanyl (Drug)

Dexmedetomidine + Fentanyl

Experimental

干预措施: Dexmedetomidine (Drug)

Fentanyl only

Experimental

干预措施: Fentanyl (Drug)

Dexmedetomidine only

Experimental

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Change in delirium scores as measured by CAPD score

时间窗: up to 10 days

次要结局

  • Drug level associated with CAPD score(up to 10 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验